Drugmakers Least Exposed in Deficit Deal

Drugmakers Least Exposed in Deficit Deal Play

Oct. 23 (Bloomberg) –- Matt Barry, a health-care analyst with Bloomberg Government, discusses how a deficit reduction deal involving Medicare and Medicaid may affect the five largest publicly traded home health providers and nursing homes more than drugmakers. Barry outlines the findings in a Bloomberg Government Study, “Home Health Providers At Risk in Deficit Deal, Not So Drugmakers.” (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    Studio 1.0: Scooter Braun Watch Now

  • Next

    Studio 1.0: Marc Andreessen

blog comments powered by Disqus